CTLA4 and cancer: Researchers have found a number of immune checkpoint signals in cancers that could confer strong immunosuppression on cancer cells by combining ligands with inhibitory immunoreceptors, such as PD-1, TIGIT, CTLA-4, BTLA, LAG3, and TIM3 [44].